Table 2.
Proposed pathophysiological mechanisms linking PDB to ocular complications
| Ocular Complication | Dominant Mechanism | Pathophysiological Process | Key Molecular/Cellular Pathways |
|---|---|---|---|
|
Orbital Deformity (Proptosis, Enophthalmos) |
Bone Remodeling/ Mechanical |
Disordered osteoclastic-osteoblastic activity leads to expansion and deformation of orbital bones, altering orbital volume and anatomy | Dysregulation of osteoclast-osteoblast coupling (RANKL/OPG, SQSTM1/p62, OPTN signal paths) |
|
Ptosis secondary to Orbital GCT |
Bone Remodeling/ Mechanical (Mass Effect) |
PDB-associated proliferation of osteoclast precursors forms a benign, space-occupying tumor that mechanically compresses the levator palpebrae superioris muscle | Local clonal expansion of osteoclast precursors driven by the systemic PDB milieu; potential role of ZNF687 mutations |
|
Compressive Optic Neuropathy (JPD) |
Bone Remodeling/ Mechanical |
Craniofacial hyperostosis, particularly of the sphenoid bone, results in stenosis of the bony optic canal, causing direct compression and ischemia of the optic nerve | Uncontrolled osteoblastic bone formation at specific cranial sites |
|
Vascular Optic Neuropathy |
Vascular/ Hemodynamic |
Hypervascularity of pagetic bone creates a low-resistance shunt (“steal” phenomenon), diverting blood flow from the microvasculature of the optic nerve head and leading to ischemia | VEGF-mediated pathological angiogenesis within pagetic bone; altered local hemodynamics |
|
Orbital & Conjunctival Congestion |
Vascular/ Hemodynamic |
Increased blood flow and vascular permeability from adjacent active pagetic bone cause venous engorgement and edema in orbital soft tissues and conjunctiva | Inflammatory cytokine release (e.g., IL-6) and angiogenic drive from the bone microenvironment |
| AS |
Metabolic/ Systemic |
Systemic dysregulation of mineral homeostasis, due to loss of calcification inhibitors, results in pathological calcification and increased fragility of Bruch’s membrane | Loss-of-function mutations in TNFRSF11B (encoding OPG), a key regulator of extracellular matrix mineralization |
|
Cataract & Maculopathy (Potential Association) |
Other/Systemic (Speculative) |
A shared systemic milieu of chronic inflammation and oxidative stress may potentially accelerate age-related degenerative processes in the lens and retina | Persistent activation of NF-κB and impairment of the NRF2 antioxidant pathway, as observed in pagetic bone biology |
Abbreviations: Paget’s disease of bone (PDB), Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL), Osteoprotegerin (OPG), Sequestosome1 (SQSTM1), Optineurin (OPTN), Giant Cell Tumor (GGT), Zinc Finger Protein 687 (ZNF687), Juvenile Paget’s Disease (JPD), Vascular Endothelial Growth Factor (VEGF), Interleukin-6 (IL-6), Angioid Streak s(AS), Tumor Necrosis Factor Receptor Superfamily Member 11B (TNFRSF11B), Nuclear Factor Kappa B (NF-κB), Nuclear Factor Erythroid 2–Related Factor 2 (NRF2)